Unknown

Dataset Information

0

Hypoxia-Targeted Drug Q6 Induces G2-M Arrest and Apoptosis via Poisoning Topoisomerase II under Hypoxia.


ABSTRACT: In spite of the tremendous efforts dedicated to developing hypoxia-activated prodrugs, no agents yet have been approved for clinical therapy. In the present study, the hypoxic selective anti-cancer activity as well as the cellular target of a novel tirapazamine (TPZ) analogue, 7-methyl-3-(3-chlorophenyl)-quinoxaline-2-carbonitrile 1,4-dioxide (Q6) were investigated. Q6 implemented anti-cancer effects via poisoning topoisomerase II (topo II) under hypoxia. Modified trapped in agarose DNA immunostaining (TARDIS) assay showed more topo II-DNA cleavage complexes trapped by Q6 than TPZ at even lower concentration. In addition, by introducing ataxia-telangiectasia-mutated (ATM) kinase inhibitors caffeine and KU-60019, we displayed that Q6-triggered apoptosis was attributed, at least partially, to DNA double-strand breaks generated by the topo II-targeting effect. Collectively, Q6 stood out for its better hypoxia-selectivity and topo II-poisoning than the parental compound TPZ. All these data shed light on the research of Q6 as a promising hypoxia-activated prodrug candidate for human hepatocellular carcinoma therapy.

SUBMITTER: Chang L 

PROVIDER: S-EPMC4674137 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hypoxia-Targeted Drug Q6 Induces G2-M Arrest and Apoptosis via Poisoning Topoisomerase II under Hypoxia.

Chang Linlin L   Liu Xiaowen X   Wang Dandan D   Ma Jian J   Zhou Tianyi T   Chen Ying Y   Sheng Rong R   Hu Yongzhou Y   Du Ying Y   He Qiaojun Q   Yang Bo B   Zhu Hong H  

PloS one 20151209 12


In spite of the tremendous efforts dedicated to developing hypoxia-activated prodrugs, no agents yet have been approved for clinical therapy. In the present study, the hypoxic selective anti-cancer activity as well as the cellular target of a novel tirapazamine (TPZ) analogue, 7-methyl-3-(3-chlorophenyl)-quinoxaline-2-carbonitrile 1,4-dioxide (Q6) were investigated. Q6 implemented anti-cancer effects via poisoning topoisomerase II (topo II) under hypoxia. Modified trapped in agarose DNA immunost  ...[more]

Similar Datasets

| S-EPMC2876597 | biostudies-literature
| S-EPMC4632281 | biostudies-literature
| S-EPMC8908320 | biostudies-literature
| S-EPMC3899331 | biostudies-literature
| S-EPMC5438718 | biostudies-literature
| S-EPMC2714234 | biostudies-literature
| S-EPMC5841811 | biostudies-literature
| S-EPMC7806519 | biostudies-literature
| S-EPMC5787485 | biostudies-literature
| S-EPMC3076712 | biostudies-literature